PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+9.98%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.34B
AUM Growth
+$1.34B
(-0.33%)
Cap. Flow
-$45.7M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
67.32%
Holding
46
New
4
Increased
17
Reduced
9
Closed
3
Top Buys
| 1 |
Insmed
INSM
|
$38.2M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$36.6M |
| 3 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$28.3M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
$25.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$25.2M |
Top Sells
| 1 |
ITMN
INTERMUNE INC
ITMN
|
$227M |
| 2 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$20.3M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$12.5M |
| 4 |
Amicus Therapeutics
FOLD
|
$12M |
| 5 |
CYBX
CYBERONICS INC
CYBX
|
$4.83M |
Sector Composition
| 1 | Healthcare | 56.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$13.8B
| $167M | 12.48% | 1,298,828 +85,000 | +7% | +$10.9M |
|
|
AUXL
2
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $145M | 10.83% | 4,854,631 | – | – |
|
|
CBST
3
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $122M | 9.14% | 1,843,688 +316,772 | +21% | +$21M |
|
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $91.2M | 6.82% | 1,264,397 +348,810 | +38% | +$25.2M |
|
|
CYBX
5
DELISTED
CYBERONICS INC
CYBX
| $82.9M | 6.2% | 1,621,101 -94,329 | -5% | -$4.83M |
|
|
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
| $78.1M | 5.83% | 1,721,757 +806,436 | +88% | +$36.6M |
|
|
ABMD
7
DELISTED
Abiomed Inc
ABMD
| $60.3M | 4.51% | 2,429,524 +222,035 | +10% | +$5.51M |
|
|
ANAC
8
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $51.8M | 3.87% | 2,116,665 +455,053 | +27% | +$11.1M |
|
|
AMAG
9
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $51.5M | 3.85% | 1,614,536 | – | – |
|
|
10
Insmed
INSM
$28.8B
| $50.8M | 3.79% | 3,892,199 +2,930,098 | +305% | +$38.2M |
|
|
NPSP
11
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $44.2M | 3.3% | 1,699,562 +1,090,262 | +179% | +$28.3M |
|
|
KYTH
12
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $36.1M | 2.7% | 1,102,181 +152,222 | +16% | +$4.99M |
|
13
Vanda Pharmaceuticals
VNDA
$279M
| $34.1M | 2.55% | 3,283,124 +42,700 | +1% | +$443K |
|
|
SQNM
14
DELISTED
SEQUENOM INC NEW
SQNM
| $29.1M | 2.18% | 9,810,442 | – | – |
|
15
STAAR Surgical
STAA
$1.36B
| $27.6M | 2.06% | 2,599,553 | – | – |
|
|
WMGI
16
DELISTED
Wright Medical Group Inc
WMGI
| $25.2M | 1.89% | +832,729 | New | +$25.2M |
|
17
Gilead Sciences
GILD
$140B
| $17.8M | 1.33% | 167,500 +13,100 | +8% | +$1.39M |
|
|
MNTA
18
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $16.5M | 1.23% | 1,455,176 | – | – |
|
|
SHPG
19
DELISTED
Shire pic
SHPG
| $16.5M | 1.23% | 63,700 | – | – |
|
|
ALIM
20
DELISTED
Alimera Sciences, Inc.
ALIM
| $16.5M | 1.23% | 3,040,260 -594,724 | -16% | -$3.22M |
|
|
CELG
21
DELISTED
Celgene Corp
CELG
| $16.3M | 1.22% | 171,600 +16,420 | +11% | +$1.56M |
|
|
EIGR
22
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $15.2M | 1.14% | 1,457,200 -11,100 | -0.8% | -$116K |
|
23
Exact Sciences
EXAS
$8.98B
| $15.1M | 1.13% | 777,676 | – | – |
|
24
Prothena Corp
PRTA
$441M
| $14.9M | 1.12% | 673,818 +139,800 | +26% | +$3.1M |
|
|
MDVN
25
DELISTED
MEDIVATION, INC.
MDVN
| $12.9M | 0.96% | 130,100 +7,200 | +6% | +$712K |
|